Enhancing Readability of Lay Abstracts and Summaries for Medical Knowledge Using Generative Artificial Intelligence (BRIDGE AI 3)
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- University of Southern California
- Study ID
- NCT07568444
- Phase
- PHASE2
- Status
- Completed
Conditions
- Bladder Cancer
- Kidney Cancers
- Prostate Cancer (Adenocarcinoma)
- Testis Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Pub2Post — OTHERPub2Post, a generative artificial intelligence agent which helps in drafting the layperson abstracts and summaries
Study Details
This trial tests if AI can help make medical info clear and readable. Many patients struggle to find medical informations that easy to read and understand from verified medical sources. The study tests if an AI tool can assist health providers to craft clear text for patients more fast than what they do now. Health providers are split at random into two groups-one uses the AI tool and one does not. The trial tests how clear the text is, how correct it is, and how much time is saved. The aim is to see if AI can close the gap between complex research and what patients can grasp.
Key Dates
- Start date
- Jan 16, 2025
- Status verified
- May 2026
- Primary completion
- Jan 22, 2025
- Completion
- Feb 27, 2025
Study Design
- Enrollment
- 120 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: Gold Standard
- Experimental: Pub2Post
Primary Outcome Measure
Readability Change [ Time Frame: The assessment will be conducted immediately after the study closes, which will occur 4 weeks after enrollment. ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Southern California | Los Angeles | California | 91100 | - |
Find similar trials in Los Angeles, CA
Related Studies
- Blue Light Cystoscopy With Cysview® RegistryRecruiting · Photocure · Birmingham, Alabama
- A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder CancerRecruiting · Cedars-Sinai Medical Center · Los Angeles, California
- A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder CancerRecruiting · Cedars-Sinai Medical Center · Long Beach, California
- Measuring Surgical Recovery After Radical CystectomyRecruiting · M.D. Anderson Cancer Center · San Francisco, California